Development of a TGFβ—IL-2/15 Switch Receptor for Use in Adoptive Cell TherapyCarole Beck(Oslo University Hospital), Jon Amund Kyte(Oslo University Hospital)BiomedicinesFebruary 4, 202310.3390/biomedicines11020459Cited by 18SaveCiteExport RISWatch citationsRelated PapersMediator of DNA Damage Checkpoint Protein 1 Facilitates V(D)J Recombination in Cells Lacking DNA Repair Factor XLF|Biomolecules|2019|26